Navigation Links
EBRI Policy Forum: Large Employers Continue to Offer Health Benefits
Date:2/7/2008

WASHINGTON, Feb. 7 /PRNewswire-USNewswire/ -- Large employers say they are not ready to bail out of their role of acting as the backbone of health insurance coverage in the United States, according to an article published today by the nonpartisan Employee Benefit Research Institute (EBRI). But the article also notes that large employers are pushing for changes they hope will alleviate the rising costs of health benefits, and the current picture could shift quickly if one large employer drops benefits.

Large employers have not settled on one model for the changes they are seeking and are not convinced that new consumer-directed health plans are the solution, reports the article in the February 2008 EBRI Notes, which summarizes discussion at EBRI's December 2007 policy forum. Moreover, some of the changes the employers are talking about could be as much as a decade in the future. The article is available online at http://www.ebri.org.

Although employers that offer health benefits say they remain committed to the current system, the article notes they are watching competitors closely. If one big sponsor takes the first step and decides to drop benefits, others say they would likely follow.

Even though employers are very concerned about rising health benefit costs, they say they continue to support an employment-based system because they believe they will end up paying "one way or the other" and because they believe the most innovation comes out of the private sector, not out of the government sector, the article says.

The policy forum sought to assess reports that the U.S. employment-based health benefits system has reached a "tipping point" because of rising costs. Despite claims of the demise of the employment-based system, EBRI data presented at the forum showed that, historically, there has been general stability in terms of workers being eligible for benefits, the perc
'/>"/>

SOURCE Employee Benefit Research Institute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
2. Chinas 1-child policy could backfire on its elderly
3. Education Key Focus of Michigan Policy Summit
4. Consumer Group: Hillary Clintons Mandatory Health Insurance Purchase Plan is an Act of War on the Middle Class Family That Cant Afford $12k Policy
5. SATELLITE BROADCAST: Consumer Group Says Hillary Clintons Mandatory Health Insurance Plan is an Act of War on the Middle Class that Cant Afford $12k Policy
6. First-in-the-Nation Health Care Billing Policy Announced in Minnesota
7. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
8. Global Leaders Converge for Special Olympics Global Policy Summit
9. Wellpoint NextRx Receives TIPPS Certification from the HR Policy Association
10. National Medical Association Selects New Director of Health Policy
11. Schwarzenegger Signs Bill to Remove Written Informed Consent for HIV Testing; "Most Important Change in Public HIV/AIDS Policy in Years," Says AHF
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)... Though the number of jobs created i... companies reported a different kind of slowdown: ...s months. , Seattle, WA (...created in the medical field slowed in June overal...ind of slowdown that will be music to the ears of ...
(Date:7/25/2008)... supporting the US Department of Defense and Feder... Phoenix. Operation Golden Phoenix is a, four-da...ned to assist, federal, state and local agencies w...os. Dataline is providing a vital, ad-hoc, secure ... use during the exercise., NORFOLK, Va., July 25 ...
(Date:7/25/2008)...elationship Based on Significant Improvements in M...MDdatacor, Inc., a leader in health,care quality m..., today,announced it has entered into a long-term ...rt Wellmark,s Collaboration on Quality(SM) Incent ...ion between Wellmark and,primary care clinicians t...
(Date:7/25/2008)...URG, Ill., July 25 /PRNewswire/ -- Sagent Pharmace...utical company, today announced that it,has launch...arrhythmic,indicated for the treatment and prophyl...ion and hemodynamically unstable ventricular,tachy... heart beat.,Sagent,s amiodarone HCl injection wil...
Breaking Medicine News(10 mins):Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 3Health News:Dataline Announces Participation in Operation Golden Phoenix 2Health News:Dataline Announces Participation in Operation Golden Phoenix 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3
... that there is an increase in number of children c...ers asked for tougher action// to tackle young cri...children under the age of 16 charged for criminal ...0 % in the past year. The crimes include violence,...
...dy language comes easy and our response is often b...phrenia,// may have a difficulty and not be able ...izophrenia, even those who have mild to moderate s...uent in understanding body language, according to ...
...ating in the anti-reservation protest have stated ...e Government rolls back plans for reservation of s...s have collapsed and nearly 300 have been provided...inite strike of resident doctors in five governmen...
... Annual Meeting of the American Society of Hyperte...ween the female sexual dysfunction// (FSD) and hig...d that mostly women with increased hypertension an...ysfunction is defined as persistent or recurring d...
Other Medicine News:Health News:Schizophrenia impairs body language comprehension 2Health News:Schizophrenia impairs body language comprehension 3Health News:Doctors Urge Government To Roll Back Quotas 2Health News:Link Established Between FSD and High Blood Pressure 2
(Date:7/23/2008)... SAN FRANCISCO, July 23 /- InCode Bio... company, today announced preclinical test,results...idate rC3-1 for,the treatment of the rare chronic ... (PNH). The complete results will be presented at ...l, Switzerland, September 28,2008., The only tre...
(Date:7/22/2008)... - Strong efficacy results from a multi-center 293....com , Toronto Stock Exchange Symbol: CYT, MONTR...Technologies,Inc., the global leader in cryotherap...ounced that results previously presented from thre...product, Arctic Front(R),were published earlier t...
(Date:7/22/2008)...Study Demonstrates Feasibility and Efficacy of Tre...ry Liver Cancer, SAN FRANCISCO, and YONGIN-SI, So...(San Francisco, CA and Ottawa, Ontario), and its S...oday that novel findings from,a Phase I clinical t...onstrated that the product was well-tolerated and ...
(Date:7/22/2008)... SOUTH SAN FRANCISCO, Calif., July 22 /PRNewswire/...at it has completed patient enrollment,in its Phas...ability and,ammonia scavenging effects of HPN-100 ...phenylbutyrate) in patients with urea cycle disord...results in the fourth quarter,of this year., (Log...
Breaking Medicine Technology:InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2CryoCath Arctic Front(R) Results Published in JACC 2CryoCath Arctic Front(R) Results Published in JACC 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 2Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 3Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3New Jersey Leaders Join Forces to Battle Chronic Disease 16998 1New Jersey Leaders Join Forces to Battle Chronic Disease 16998 2New Jersey Leaders Join Forces to Battle Chronic Disease 16998 3New Jersey Leaders Join Forces to Battle Chronic Disease 16998 4NYU Medical Center Changes Name to Honor Chairman of Board 26 Wife 4649 1NYU Medical Center Changes Name to Honor Chairman of Board 26 Wife 4649 2NYU Medical Center Changes Name to Honor Chairman of Board 26 Wife 4649 3NYU Medical Center Changes Name to Honor Chairman of Board 26 Wife 4649 4NYU Medical Center Changes Name to Honor Chairman of Board 26 Wife 4649 5Low Vitamin D Levels Linked to Leg Artery Blockages 16994 1Low Vitamin D Levels Linked to Leg Artery Blockages 16994 2Low Vitamin D Levels Linked to Leg Artery Blockages 16994 3Older people are nations happiest 16991 1Older people are nations happiest 16991 2
... in a randomized phase II/III clinical trial,antic...Newswire-FirstCall/ -- Cell,Therapeutics, Inc. (CT...s, which demonstrate that treatment with pixantron... cardiotoxicity, while,doxorubicin and mitoxantron...compared the cardiac side effects of equiactive do...
....--(BUSINESS WIRE)--Jun 26, 2007 - Sirtris,Pharmac... company,focused on discovering and developing sma...unced today that activation of SIRT1, a,member of ...t,against neurodegenerative diseases such as Alzhe...n animal models. These findings,appear in an artic...
Other Medicine Technology:Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 2Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 3Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 4Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 5Publication on Pixantrone Preclinical Studies Demonstrates Reduced,Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and,Mitoxantrone 6Resveratrol Studies Suggest Broad Implications for SIRT1 Activation,in Neurodegenerative Diseases of Aging Such as Alzheimer's Disease 2Resveratrol Studies Suggest Broad Implications for SIRT1 Activation,in Neurodegenerative Diseases of Aging Such as Alzheimer's Disease 3
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: